Cargando…
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease
The efficacy of reduced intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (HCT) for Ph+ acute lymphoblastic leukemia (ALL) is uncertain. We analyzed 197 adults with Ph+ ALL in first complete remission; 67 patients receiving RIC were matched with 130 receiving myeloablative c...
Autores principales: | Bachanova, Veronika, Marks, David I., Zhang, Mei-Jie, Wang, Hailin, de Lima, Marcos, Aljurf, Mahmoud D., Arellano, Martha, Artz, Andrew S., Bacher, Ulrike, Cahn, Jean-Yves, Chen, Yi-Bin, Copelan, Edward A., Drobyski, William R., Gale, Robert Peter, Greer, John P, Gupta, Vikas, Hale, Gregory A., Kebriaei, Partow, Lazarus, Hillard M., Lewis, Ian D., Lewis, Victor A., Liesveld, Jane L., Litzow, Mark R., Loren, Alison W., Miller, Alan M., Norkin, Maxim, Oran, Betul, Pidala, Joseph, Rowe, Jacob M., Savani, Bipin N., Saber, Wael, Vij, Ravi, Waller, Edmund K., Wiernik, Peter H., Weisdorf, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951192/ https://www.ncbi.nlm.nih.gov/pubmed/23989431 http://dx.doi.org/10.1038/leu.2013.253 |
Ejemplares similares
-
SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS
por: Luger, Selina M., et al.
Publicado: (2011) -
Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
por: Popat, Uday R., et al.
Publicado: (2023) -
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study
por: Popat, Uday R., et al.
Publicado: (2022) -
Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR
por: Wieduwilt, Matthew J., et al.
Publicado: (2021) -
Comparison of Non-myeloablative Conditioning Regimens for Lymphoproliferative Disorders
por: Hong, Sanghee, et al.
Publicado: (2014)